These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10219467)

  • 1. Pharmacokinetics of latanoprost in the cynomolgus monkey. 2nd communication: repeated topical administration on the eye.
    Sjöquist B; Uhlin A; Byding P; Stjernschantz J
    Arzneimittelforschung; 1999 Mar; 49(3):234-9. PubMed ID: 10219467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of latanoprost in the cynomolgus monkey. 1st communication: single intravenous, oral or topical administration on the eye.
    Sjöquist B; Tajallaei S; Stjernschantz J
    Arzneimittelforschung; 1999 Mar; 49(3):225-33. PubMed ID: 10219466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of latanoprost in the cynomolgus monkey. 3rd communication: tissue distribution after topical administration on the eye studied by whole body autoradiography. Glaucoma Research Laboratories.
    Sjöquist B; Johansson A; Stjernschantz J
    Arzneimittelforschung; 1999 Mar; 49(3):240-9. PubMed ID: 10219468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit.
    Sjöquist B; Basu S; Byding P; Bergh K; Stjernschantz J
    Drug Metab Dispos; 1998 Aug; 26(8):745-54. PubMed ID: 9698288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular and systemic pharmacokinetics of latanoprost in humans.
    Sjöquist B; Stjernschantz J
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S6-12. PubMed ID: 12204697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
    Fukano Y; Kawazu K
    Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF; Gagliuso DJ; Mittag TW; Podos SM
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and ocular tissue distribution of an antiglaucoma prostanoid, tafluprost, after ocular instillation to monkeys.
    Fukano Y; Kawazu K; Akaishi T; Bezwada P; Pellinen P
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):251-9. PubMed ID: 21491995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latanoprost systemic exposure in pediatric and adult patients with glaucoma: a phase 1, open-label study.
    Raber S; Courtney R; Maeda-Chubachi T; Simons BD; Freedman SF; Wirostko B;
    Ophthalmology; 2011 Oct; 118(10):2022-7. PubMed ID: 21788077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment.
    Stjernschantz J; Selén G; Astin M; Resul B
    Prog Retin Eye Res; 2000 Jul; 19(4):459-96. PubMed ID: 10785618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability in the human eye of a fixed combination of latanoprost and timolol compared to monotherapy.
    Calissendorff B; Sjöquist B; Högberg G; Grunge-Lowerud A
    J Ocul Pharmacol Ther; 2002 Apr; 18(2):127-31. PubMed ID: 12002666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans.
    Ishii K; Tomidokoro A; Nagahara M; Tamaki Y; Kanno M; Fukaya Y; Araie M
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2957-63. PubMed ID: 11687542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular hypotensive effect of tafluprost in latanoprost low-responder cynomolgus monkeys.
    Kurashima H; Asai Y; Aihara M; Ishida N; Nakamura M; Araie M
    J Glaucoma; 2012 Feb; 21(2):123-8. PubMed ID: 21423041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.